Cargando…
A new allergic rhinitis therapy (MP29-02*) provides effective and rapid symptom relief for patients who suffer most from the bothersome symptoms of nasal congestion or ocular itch
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493484/ http://dx.doi.org/10.1186/2045-7022-5-S4-P33 |
_version_ | 1782379924782317568 |
---|---|
author | Fokkens, Wytske Hellings, Peter Mullol, Joaquim Munzel, Ullrich Bachert, Claus |
author_facet | Fokkens, Wytske Hellings, Peter Mullol, Joaquim Munzel, Ullrich Bachert, Claus |
author_sort | Fokkens, Wytske |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4493484 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-44934842015-07-15 A new allergic rhinitis therapy (MP29-02*) provides effective and rapid symptom relief for patients who suffer most from the bothersome symptoms of nasal congestion or ocular itch Fokkens, Wytske Hellings, Peter Mullol, Joaquim Munzel, Ullrich Bachert, Claus Clin Transl Allergy Poster Presentation BioMed Central 2015-06-26 /pmc/articles/PMC4493484/ http://dx.doi.org/10.1186/2045-7022-5-S4-P33 Text en Copyright © 2015 Fokkens et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Poster Presentation Fokkens, Wytske Hellings, Peter Mullol, Joaquim Munzel, Ullrich Bachert, Claus A new allergic rhinitis therapy (MP29-02*) provides effective and rapid symptom relief for patients who suffer most from the bothersome symptoms of nasal congestion or ocular itch |
title | A new allergic rhinitis therapy (MP29-02*) provides effective and rapid symptom relief for patients who suffer most from the bothersome symptoms of nasal congestion or ocular itch |
title_full | A new allergic rhinitis therapy (MP29-02*) provides effective and rapid symptom relief for patients who suffer most from the bothersome symptoms of nasal congestion or ocular itch |
title_fullStr | A new allergic rhinitis therapy (MP29-02*) provides effective and rapid symptom relief for patients who suffer most from the bothersome symptoms of nasal congestion or ocular itch |
title_full_unstemmed | A new allergic rhinitis therapy (MP29-02*) provides effective and rapid symptom relief for patients who suffer most from the bothersome symptoms of nasal congestion or ocular itch |
title_short | A new allergic rhinitis therapy (MP29-02*) provides effective and rapid symptom relief for patients who suffer most from the bothersome symptoms of nasal congestion or ocular itch |
title_sort | new allergic rhinitis therapy (mp29-02*) provides effective and rapid symptom relief for patients who suffer most from the bothersome symptoms of nasal congestion or ocular itch |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493484/ http://dx.doi.org/10.1186/2045-7022-5-S4-P33 |
work_keys_str_mv | AT fokkenswytske anewallergicrhinitistherapymp2902provideseffectiveandrapidsymptomreliefforpatientswhosuffermostfromthebothersomesymptomsofnasalcongestionorocularitch AT hellingspeter anewallergicrhinitistherapymp2902provideseffectiveandrapidsymptomreliefforpatientswhosuffermostfromthebothersomesymptomsofnasalcongestionorocularitch AT mulloljoaquim anewallergicrhinitistherapymp2902provideseffectiveandrapidsymptomreliefforpatientswhosuffermostfromthebothersomesymptomsofnasalcongestionorocularitch AT munzelullrich anewallergicrhinitistherapymp2902provideseffectiveandrapidsymptomreliefforpatientswhosuffermostfromthebothersomesymptomsofnasalcongestionorocularitch AT bachertclaus anewallergicrhinitistherapymp2902provideseffectiveandrapidsymptomreliefforpatientswhosuffermostfromthebothersomesymptomsofnasalcongestionorocularitch AT fokkenswytske newallergicrhinitistherapymp2902provideseffectiveandrapidsymptomreliefforpatientswhosuffermostfromthebothersomesymptomsofnasalcongestionorocularitch AT hellingspeter newallergicrhinitistherapymp2902provideseffectiveandrapidsymptomreliefforpatientswhosuffermostfromthebothersomesymptomsofnasalcongestionorocularitch AT mulloljoaquim newallergicrhinitistherapymp2902provideseffectiveandrapidsymptomreliefforpatientswhosuffermostfromthebothersomesymptomsofnasalcongestionorocularitch AT munzelullrich newallergicrhinitistherapymp2902provideseffectiveandrapidsymptomreliefforpatientswhosuffermostfromthebothersomesymptomsofnasalcongestionorocularitch AT bachertclaus newallergicrhinitistherapymp2902provideseffectiveandrapidsymptomreliefforpatientswhosuffermostfromthebothersomesymptomsofnasalcongestionorocularitch |